Related Experiment Video

Updated: Jun 23, 2026

Isolation, Culture, and Functional Characterization of Adult Mouse Cardiomyoctyes
12:49

Isolation, Culture, and Functional Characterization of Adult Mouse Cardiomyoctyes

Published on: September 25, 2013

Troponin-tropomyosin abnormalities in hamster cardiomyopathy

A Malhotra1, J Scheuer

  • 1Department of Medicine, Montefiore Medical Center, Bronx, New York 10467.

The Journal of Clinical Investigation
|July 1, 1990
PubMed

Insights

Cardiomyopathic hamster hearts show abnormal Mg2+ ATPase activity. Replacing troponin-tropomyosin (Tn.Tm) with normal Tn.Tm partially corrects this, suggesting Tn.Tm dysfunction contributes to heart muscle disease.

Area of Science:

  • Biochemistry
  • Cardiovascular Biology
  • Muscle Physiology

Background:

  • Cardiac myofibrils from cardiomyopathic hamsters display altered Mg2+ ATPase activity and calcium responsiveness.
  • Understanding the underlying molecular mechanisms is crucial for developing therapeutic strategies.

Purpose of the Study:

  • To investigate the role of troponin-tropomyosin (Tn.Tm) complex in the altered ATPase activity of cardiomyopathic hamster cardiac myofibrils.
  • To determine if Tn.Tm from healthy hearts can restore normal function to diseased myofibrils.

Main Methods:

  • Incubation of myofibrils from control and cardiomyopathic hamsters with isolated Tn.Tm complexes from various sources (control hamster, cardiomyopathic hamster, dog).
  • Enzymatic assays to measure Mg2+ and Ca2+ ATPase activities.
  • Electrophoresis and autoradiography to confirm binding of Tn.Tm to myofibrils.

Main Results:

  • Tn.Tm from control hamster or dog hearts partially restored normal Mg2+ ATPase activity to cardiomyopathic myofibrils.
  • Maximum Ca2+ stimulated ATPase activity remained lower in cardiomyopathic myofibrils, even with control Tn.Tm.
  • Binding studies confirmed Tn.Tm complex attaches to myofibrils, with no significant differences in binding efficiency observed.

Conclusions:

  • The troponin-tropomyosin complex in cardiomyopathic hamster hearts exhibits altered regulatory properties, partially inhibiting Mg2+ myofibrillar ATPase activity.
  • Reduced Ca2+ responsiveness in cardiomyopathic myofibrils may stem from Tn.Tm abnormalities and/or intrinsic myosin dysfunction.

More Related Videos

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

Analysis of Cardiac Contractile Dysfunction and Ca2+ Transients in Rodent Myocytes07:32

Analysis of Cardiac Contractile Dysfunction and Ca2+ Transients in Rodent Myocytes

Published on: May 25, 2022

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...